Mr Valluru: Industry subscription

Please open the online version of this message if the HTML is not correctly displayed. www.drugdiscoverytoday.com Drug Discovery Today: Complimentary Digital Copies   Key review areas for 2009: • Therapeutics • Virtual Screening • Molecular biology • Bioinformatics • Receptors and channels • Medicinal chemistry • Spectroscopy • Drug delivery • Cell/tissue culture • Medicinal chemistry • Gene expression analysis • Lab automation/HTS   Dear Mr Valluru, Drug Discovery Today is offering you the chance to register for a year's worth of complimentary digital copies. Packed full of the best coverage of rapid scientific developments, opinionated editorials, interviews and business trends, Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 7.7. To see a sample copy of our digital edition, simply click here. Drug Discovery Today publishes reviews covering the whole of the preclinical drug discovery process, from target identification and validation to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, and the translation of these sciences to therapies. To sign up, simply go to: http://www.subscription.co.uk/cc/ddt/0085 To ensure you receive the next copy of Drug Discovery Today for FREE, you need to register by 27 March 2009. I look forward to hearing from you. Best Regards, Steve Carney Editor Drug Discovery Today www.drugdiscoverytoday.com Data Protection Notice This e-mail has been sent to manojhind2001us1.stemcell@blogger.com from Elsevier Ltd., The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, registered in England with registered number 1982084, using Email Reaction's technology and platform. To ensure delivery to your inbox (not bulk or junk folders), please click here to add our address to your safe senders list. You are receiving this e-mail because you are a registered user of ScienceDirect® and have consented to receive information about related products. If you do not wish to receive general marketing messages from Elsevier Drug Discovery Journals, you can visit this page to Unsubscribe, enter your email address, and press the submit button and you will be unsubscribed. To update your ScienceDirect profile please go to the ScienceDirect website, login with your username and password and amend your preferences. Elsevier respects your privacy and does not disclose, sell or rent your personal information to any non-affiliated third parties without your consent, except as may be stated in the Elsevier Privacy Policy. Please visit this page to see Email Reaction's Privacy Policy. For all enquiries, problems or suggestions regarding this service, please contact: ddt@drugdiscoverytoday.com. Copyright © 2009 Elsevier Ltd. all rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.